These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 8720290)

  • 61. Treatment of patients with hepatitis C virus on the waiting list.
    Everson GT
    Liver Transpl; 2003 Nov; 9(11):S90-4. PubMed ID: 14586902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Severe relapse of hepatitis C following liver transplantation. Successful treatment with a combination of interferon-alpha and ribavirin].
    Telegdy L; Görög D; Horányi M; Schaff Z
    Orv Hetil; 1999 Aug; 140(34):1891-3. PubMed ID: 10502972
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
    Moreno Planas JM; Rubio Gonzalez E; Boullosa Graña E; Garrido Botella A; Barrios Peinado C; Lucena Poza JL; Jiménez Garrido M; Sanchez Turrion V; Cuervas-Mons Martinez V
    Transplant Proc; 2005 Jun; 37(5):2207-8. PubMed ID: 15964380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation.
    Castedal M; Siewert-Delle A; Olausson M; Friman S
    Transplant Proc; 2003 Mar; 35(2):820-1. PubMed ID: 12644153
    [No Abstract]   [Full Text] [Related]  

  • 65. Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study.
    Beckebaum S; Cicinnati VR; Zhang X; Malago M; Dirsch O; Erim Y; Frilling A; Broelsch CE; Gerken G
    Transplant Proc; 2004 Jun; 36(5):1489-91. PubMed ID: 15251366
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin.
    Tang S; Cheng IK; Leung VK; Kuok UI; Tang AW; Wing Ho Y; Neng Lai K; Mao Chan T
    J Hepatol; 2003 Nov; 39(5):875-8. PubMed ID: 14568274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation.
    Smallwood GA; Davis L; Connor K; Martinez E; Stieber AC; Heffron TG
    Transplant Proc; 2003 Jun; 35(4):1476-7. PubMed ID: 12826197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatitis C recurrence in liver transplant recipients.
    Kizilisik TA; al-Sebayel M; Hammad A; al-Traif I; Ramirez CG; Abdulla A
    Transplant Proc; 1997 Nov; 29(7):2875-7. PubMed ID: 9365599
    [No Abstract]   [Full Text] [Related]  

  • 69. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Duclos-Vallée JC; Féray C; Sebagh M; Teicher E; Roque-Afonso AM; Roche B; Azoulay D; Adam R; Bismuth H; Castaing D; Vittecoq D; Samuel D;
    Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.
    Götz G; Schön MR; Haefker A; Neuhaus R; Berg T; Hopf U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2104-6. PubMed ID: 9723407
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation.
    Takada Y; Ito T; Ueda Y; Haga H; Egawa H; Tanaka K; Uemoto S
    Liver Transpl; 2008 Jul; 14(7):1044-7. PubMed ID: 18581485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Current treatment of hepatitis C virus infection].
    Lörke J; Avci A; Erhardt A; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1773-7. PubMed ID: 16049884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation.
    Cicinnati VR; Iacob S; Klein CG; Baba HA; Sotiropoulos GC; Hilgard P; Erim Y; Broelsch CE; Gerken G; Beckebaum S
    Aliment Pharmacol Ther; 2007 Jul; 26(2):291-303. PubMed ID: 17593075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Treatment of hepatitis C].
    Trepo C; Habersetzer F; Bailly F; Berby F; Pichoud C; Berthillon P; Vitvitski L
    Pathol Biol (Paris); 1995 Oct; 43(8):716-24. PubMed ID: 8745594
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?
    Merli M; Gentili F; Giusto M; Attili AF; Corradini SG; Mennini G; Rossi M; Corsi A; Bianco P
    Dig Liver Dis; 2009 May; 41(5):345-9. PubMed ID: 19162574
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Limited benefit of biochemical response to combination therapy for patients with recurrent hepatitis C after living-donor liver transplantation.
    Ueda Y; Takada Y; Haga H; Nabeshima M; Marusawa H; Ito T; Egawa H; Tanaka K; Uemoto S; Chiba T
    Transplantation; 2008 Mar; 85(6):855-62. PubMed ID: 18360268
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience.
    Tamura S; Sugawara Y; Yamashiki N; Kaneko J; Kokudo N; Makuuchi M
    Transpl Int; 2010 Jun; 23(6):580-8. PubMed ID: 20028490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of hepatitis C in liver transplant recipients.
    Gordon FD; Kwo P; Vargas HE
    Liver Transpl; 2009 Feb; 15(2):126-35. PubMed ID: 19177439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.
    Mukherjee S; Gilroy RK; McCashland TM; Schafer DF
    Transplant Proc; 2003 Jun; 35(4):1478-9. PubMed ID: 12826198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial.
    Andreone P; Gramenzi A; Cursaro C; Sbolli G; Fiorino S; Di Giammarino L; Miniero R; D'Errico A; Gasbarrini G; Bernardi M
    J Hepatol; 1999 May; 30(5):788-93. PubMed ID: 10365803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.